Sirolimus in Patients With Systemic Lupus Erythematosus-Associated Immune Thrombocytopenia | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Sirolimus in Patients With Systemic Lupus Erythematosus-Associated Immune Thrombocytopenia	Cytopenia, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Purpura, Thrombocytopenic, Idiopathic, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, autoimmune disease, blood coagulation disease, blood platelet disease, connective tissue disorder, hematologic disorder, hemorrhagic disease, immune system disorder, purpura, systemic lupus erythematosus, thrombocytopenia, thrombocytopenic purpura, thrombotic microangiopathy	Recruiting	Phase 2 / Phase 3	2026-06-18		NCT07657793

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Chinese SLE Treatment And Research Group	13

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Peking Union Medical College Hospital	Beijing	China	201